US Stock MarketDetailed Quotes

OLMA Olema Pharmaceuticals

Watchlist
  • 4.295
  • -0.025-0.58%
Trading Mar 25 10:28 ET
293.49MMarket Cap-1.95P/E (TTM)

Olema Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
35.53%142.26M
20.88%36.77M
61.17%37.62M
55.22%33.53M
16.00%34.34M
-1.89%104.96M
11.75%30.42M
0.52%23.34M
-35.12%21.6M
27.30%29.6M
Selling and administrative expenses
-5.74%17.74M
-1.65%4.47M
13.01%4.4M
22.40%4.42M
-34.24%4.46M
-23.84%18.82M
-19.36%4.54M
-30.49%3.89M
-42.11%3.61M
-6.47%6.78M
-General and administrative expense
-5.74%17.74M
-1.65%4.47M
13.01%4.4M
22.40%4.42M
-34.24%4.46M
-23.84%18.82M
-19.36%4.54M
-30.49%3.89M
-42.11%3.61M
-6.47%6.78M
Research and development costs
44.55%124.52M
24.84%32.3M
70.80%33.23M
61.82%29.11M
30.92%29.88M
4.70%86.14M
19.87%25.87M
10.36%19.45M
-33.51%17.99M
42.58%22.83M
Operating profit
-35.53%-142.26M
-20.88%-36.77M
-61.17%-37.62M
-55.22%-33.53M
-16.00%-34.34M
1.89%-104.96M
-11.75%-30.42M
-0.52%-23.34M
35.12%-21.6M
-27.30%-29.6M
Net non-operating interest income expense
52.34%12.68M
-7.24%3.29M
52.58%2.93M
100.52%3.11M
156.86%3.35M
273.65%8.33M
264.95%3.55M
208.52%1.92M
273.49%1.55M
498.62%1.31M
Non-operating interest income
52.34%12.68M
-7.24%3.29M
52.58%2.93M
100.52%3.11M
156.86%3.35M
273.65%8.33M
264.95%3.55M
208.52%1.92M
273.49%1.55M
498.62%1.31M
Other net income (expense)
636.84%102K
-200.00%-93K
274.68%138K
190.91%40K
54.55%17K
29.63%-19K
38.81%93K
34.17%-79K
-320.00%-44K
83.33%11K
Other non- operating income (expenses)
636.84%102K
-200.00%-93K
274.68%138K
190.91%40K
54.55%17K
29.63%-19K
38.81%93K
34.17%-79K
-320.00%-44K
83.33%11K
Income before tax
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
Income tax
Net income
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
Net income continuous Operations
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
Minority interest income
Net income attributable to the parent company
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
Basic earnings per share
-2.80%-2.2
16.67%-0.4
-25.00%-0.6
-10.20%-0.54
20.00%-0.56
18.32%-2.14
26.15%-0.48
15.79%-0.48
40.24%-0.49
-20.69%-0.7
Diluted earnings per share
-2.80%-2.2
16.67%-0.4
-25.00%-0.6
-10.20%-0.54
20.00%-0.56
18.32%-2.14
26.15%-0.48
15.79%-0.48
40.24%-0.49
-20.69%-0.7
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 35.53%142.26M20.88%36.77M61.17%37.62M55.22%33.53M16.00%34.34M-1.89%104.96M11.75%30.42M0.52%23.34M-35.12%21.6M27.30%29.6M
Selling and administrative expenses -5.74%17.74M-1.65%4.47M13.01%4.4M22.40%4.42M-34.24%4.46M-23.84%18.82M-19.36%4.54M-30.49%3.89M-42.11%3.61M-6.47%6.78M
-General and administrative expense -5.74%17.74M-1.65%4.47M13.01%4.4M22.40%4.42M-34.24%4.46M-23.84%18.82M-19.36%4.54M-30.49%3.89M-42.11%3.61M-6.47%6.78M
Research and development costs 44.55%124.52M24.84%32.3M70.80%33.23M61.82%29.11M30.92%29.88M4.70%86.14M19.87%25.87M10.36%19.45M-33.51%17.99M42.58%22.83M
Operating profit -35.53%-142.26M-20.88%-36.77M-61.17%-37.62M-55.22%-33.53M-16.00%-34.34M1.89%-104.96M-11.75%-30.42M-0.52%-23.34M35.12%-21.6M-27.30%-29.6M
Net non-operating interest income expense 52.34%12.68M-7.24%3.29M52.58%2.93M100.52%3.11M156.86%3.35M273.65%8.33M264.95%3.55M208.52%1.92M273.49%1.55M498.62%1.31M
Non-operating interest income 52.34%12.68M-7.24%3.29M52.58%2.93M100.52%3.11M156.86%3.35M273.65%8.33M264.95%3.55M208.52%1.92M273.49%1.55M498.62%1.31M
Other net income (expense) 636.84%102K-200.00%-93K274.68%138K190.91%40K54.55%17K29.63%-19K38.81%93K34.17%-79K-320.00%-44K83.33%11K
Other non- operating income (expenses) 636.84%102K-200.00%-93K274.68%138K190.91%40K54.55%17K29.63%-19K38.81%93K34.17%-79K-320.00%-44K83.33%11K
Income before tax -33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M
Income tax
Net income -33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M
Net income continuous Operations -33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M
Minority interest income
Net income attributable to the parent company -33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M
Basic earnings per share -2.80%-2.216.67%-0.4-25.00%-0.6-10.20%-0.5420.00%-0.5618.32%-2.1426.15%-0.4815.79%-0.4840.24%-0.49-20.69%-0.7
Diluted earnings per share -2.80%-2.216.67%-0.4-25.00%-0.6-10.20%-0.5420.00%-0.5618.32%-2.1426.15%-0.4815.79%-0.4840.24%-0.49-20.69%-0.7
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
+4.22%
Ecopetrol
EC
+2.62%
Vale SA
VALE
+1.91%
Meta Platforms
META
+1.75%
Adobe
ADBE
+1.35%

Unlock the Full List